NUVB Nuvation Bio Inc. PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Nuvation Bio (NUVB) Stock: Buy, Sell, or Hold?

$4.29
+0.09 (+2.14%) ▲
5d: -9.3% 30d: -9.11% 90d: -29.67%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (84%)
Quality Score
57/100
Position
OVERSOLD
30-Day Fair Range
$4.40 – $4.87
Position: OVERSOLD
Forward P/E & Valuation
-36.2x CHEAP
vs 86.0x historical avg
Wall Street Target
$12.45
+190.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.98 / $4.85
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: NUVB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Get Alerted When NUVB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: NUVB is currently trading at $4.29, which is considered oversold relative to its 30-day fair value range of $4.40 to $4.87. From a valuation perspective, the stock is trading at a discount (Forward PE: -36.2) compared to its historical average (86.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, NUVB is in a strong downtrend. Immediate support is located at $3.98, while resistance sits at $4.85.

Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.45 (+190.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $4.40 - $4.87
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 84.3%

Trading Range & Key Levels

30-Day Trading Range $4.40 - $4.87
Current vs Trading Range OVERSOLD
Support Level $3.98
Resistance Level $4.85
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding NUVB? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (51/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 190.3% below Wall St target ($12.45)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • NEUTRAL: Bottoming setup forming (51/100) — watch for confirmation
  • CAUTION: 5-day price weakness (-9.3%) - monitor closely

Fundamental Context

Forward P/E (Next Year Est.) -36.23
Wall Street Target $12.45 (+190.3%)
Revenue Growth (YoY) 242.6%
Profit Margin -67.4%
PE vs Historical -36.2 vs 86.0 CHEAP
Share NUVB Analysis

Share this live NUVB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (NUVB)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary: Nuvation Bio (NUVB) announced that its executives will present at the Jefferies Global Healthcare Conference in London, with a live webcast and archived recording available.
Key Retail Themes: Company news Upcoming investor presentations
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:30 AM ET
Data refreshes hourly during market hours. Next update: 8:30 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for NUVB.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
28 analysts
$91 56 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 55 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 52 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
22 analysts
$107 33 SELL
WVE
Wave Life Sciences Ltd
STRONG BUY
21 analysts
$17 34 SELL

Advanced NUVB Option Strategies

Professional options setups generated by AI based on today's NUVB price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive NUVB Research Pages
NUVB Technical Chart NUVB Price Prediction NUVB Intrinsic Value DCF NUVB Earnings Date Why is NUVB Moving Today? NUVB Investment Advisor NUVB Fair Price Analyzer NUVB Options Chain NUVB Options Advisor NUVB Options Analysis NUVB Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals